Harvest Group Wealth Management, LLC Innoviva, Inc. Transaction History

Harvest Group Wealth Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 23, 2020	SELL	$8.11 - $15.23 $1,273 - $2,391	-157 Closed	0 $0
Q3 2019 Nov 01, 2019	BUY	$10.05 - $14.55 $763 - $1,105	76 Added 93.83%	157 $2,000
Q2 2019 Jul 31, 2019	SELL	$13.1 - $14.95 $1,388 - $1,584	-106 Reduced 56.68%	81 $1,000
Q1 2019 May 06, 2019	BUY	$13.69 - $20.06 $2,560 - $3,751	187 New	187 $3,000

222

79.7M

20K

5.4K

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.38B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Harvest Group Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Harvest Group Wealth Management, LLC with notifications on news.